A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre study
Explore this paper's citation graph
Summary
Evaluating the long-term outcome in 61 patients with medication-overuse headache who 4 years previously had been included in a randomized open-label prospective multicentre study found a low total HADS score at baseline was associated with the most favorable outcome.
- Type
- article
- Published
- 2011-01-05
- Cited by
- 44
- References
- 30
- Access
- Open access
- OpenAlex
- https://openalex.org/W1999314724
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:8171704
Keywords
Medicine, Hospital Anxiety and Depression Scale, Depression (economics), Randomized controlled trial, Physical therapy
References
- International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results.
- Are There Predictive Factors for Long-Term Outcome after Withdrawal in Drug-Induced Chronic Daily Headache?
- The general population.
- Reduction in medication‐overuse headache after short information. The Akershus study of chronic headache
- The International Classification of Headache Disorders (2nd ed.)
- Analgesic-induced chronic headache: long-term results of withdrawal therapy
- Medication Overuse Headache: Rates and Predictors for Relapse in a 4-year Prospective Study
- Prognosis of migraine and tension-type headache
- Chronic Daily Headache in Taipei, Taiwan: Prevalence, Follow-Up and Outcome Predictors
- Long-Term Follow-Up of Patients Treated for Chronic Headache with Analgesic Overuse
- Drug-Induced Headache: Long-Term Results of Stationary Versus Ambulatory Withdrawal Therapy
- The International Classification of Headache Disorders
- Medication overuse headache: a critical review of end points in recent follow-up studies
- Epidemiology of Chronic Daily Headache in the General Population
- Management of Medication Overuse Headache: 1-Year Randomized Multicentre Open-Label Trial
- Analgesic overuse among subjects with headache, neck, and low-back pain
- Prevalence of Secondary Chronic Headaches in a Population-Based Sample of 30-44-Year-Old Persons. The Akershus Study of Chronic Headache
- Disability in chronic migraine with medication overuse: Treatment effects through 5 years
- A narrative review on the management of medication overuse headache: the steep road from experience to evidence
- Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy
Cited by
- Klassifikation und Therapie des Medikamenten-Übergebrauch-Kopfschmerzes (MÜK)
- Update on Medication-Overuse Headache and Its Treatment
- A randomized controlled trial on medication‐overuse headache: outcome after 1 and 4 years
- Migraine-specific quality of life questionnaire and relapse of medication overuse headache
- Clinical Aspects of Medication Overuse Headaches
- Psychiatric screening for migraine patients
- Chronic migraine plus medication overuse headache: two entities or not?
- Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial.
- Quality of Life, Depression, and Anxiety 6 Months After Inpatient Withdrawal in Patients With Medication Overuse Headache: An Observational Study
- Dependency-like behaviors and pain coping styles in subjects with chronic migraine and medication overuse: results from a 1-year follow-up study
- Medication Overuse Headache
- Chronic migraine classification: current knowledge and future perspectives
- Medication Overuse Headache: History, Features, Prevention and Management Strategies
- Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages
- The impact of headache and chronic musculoskeletal complaints on the risk of insomnia: longitudinal data from the Nord-Trøndelag health study
- Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project)
- Factors associated with a negative outcome of medication-overuse headache: A 3-year follow-up (the ‘CARE’ protocol)
- Treatment of medication-overuse headache: A systematic review
- Démarche diagnostique générale devant une céphalée chronique quotidienne (CCQ) — Prise en charge d’une CCQ chez le migraineux : céphalée par abus médicamenteux et migraine chronique. Recommandations de la SFEMC, de l’ANLLF et de la SFETD
- Medication-Overuse Headache: Differences between Daily and Near-Daily Headache Patients
Related papers
- The future of neurology after the COVID-19 pandemic according to neurology residents
- Adult neurology training during child neurology residency
- Identification and interference of inpatients' anxiety
- Anxiety and depression in bronchiectasis: Response to pulmonary rehabilitation and minimal clinically important difference of the Hospital Anxiety and Depression Scale
- GENERAL MEDICAL SKILLS ON NEUROLOGY AND STROKE WARDS
- Rates of Comorbid Anxiety and Depression in Patients With Age-Related Macular Degeneration
- Poststroke Anxiety at 1 Year After Rehabilitation
- A prospective analysis of the association between cardiovascular disease and depression in middle-aged women
- A Study on Depression among Patient with Type 2 DiabetesMellitus in North-Eastcoast Malaysia